Moderna, Mitsubishi Tanabe enter JV to promote mRNA respiratory, COVID-19 shots in Japan
2024-07-09
Maddie Meyer/Getty Images News Moderna (NASDAQ:MRNA) and Mitsubishi Tanabe Pharma to co-promote Moderna’s mRNA respiratory vaccine portfolio in Japan, including Moderna’s COVID-19 vaccine, Spikevax, the companies said on Sunday. Under the joint venture agreement, Moderna (MRNA) will handle the manufacturing, sales, medical education and distribution of its mRNA respiratory vaccines.Continue Reading